Sign up Australia
Proactive Investors - Run By Investors For Investors

The Hydroponics Company details domestic medicinal cannabis production

Canndeo is building a domestic medicinal cannabis production and supply capability.
The Hydroponics Company details domestic medicinal cannabis production
Canndeo has received a cannabis research licence

The Hydroponics Company (ASX:THC) through its wholly-owned medicinal cannabis subsidiary, Canndeo Limited, is building a domestic medicinal cannabis production and supply capability.

This is being achieved through the licensing program established under the Narcotic Drugs Act 1967.

There are three relevant licences issued by the Office of Drug Control:

- A cannabis research licence allows the production of cannabis strains for research into medicinal use;

- A medicinal cannabis licence allows either cultivation or production or both of medicinal cannabis plants; and

- A manufacturing licence allows the manufacture of cannabis and cannabis extract into medicinal cannabis.

Canndeo received a cannabis research licence on 6 July 2017, and its application for a medicinal cannabis licence is progressing in its assessment and a manufacturing licence application is currently under development.

THC said that it will advise the market when the licences are granted and also with regard its domestic medicinal cannabis production and supply capability.

View full THC profile View Profile

The Hydroponics Company Ltd Timeline

Related Articles

GW_Pharma.png
January 11 2017
“[We are] entering a very exciting phase, which should result in the crystallisation of substantial value,” said chief executive, Dr Satu Vainikka.
Lab.jpg
April 05 2017
The share placing follows a period of expansion that has seen it make two major acquisition
picture of Paris
April 05 2017
Data from the European head and neck trial with lead product NBTXR3 will be presented at the ASCO meeting in June

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use